Balyasny Asset Management
AVEO

Balyasny Asset Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Balyasny Asset Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,445,068
Closed -$21.6M – 3443
2022
Q4 		$21.6M Buy
+1,445,068
New +$20M 0.06% 461

Balyasny Asset Management's AVEO Position: Q1 2023 in Review

Balyasny Asset Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 1,445,068 shares — an estimated $21.6M sold.

Balyasny Asset Management first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $21.6M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Balyasny Asset Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 1,445,068 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $21.6M.
  • Balyasny Asset Management first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • Balyasny Asset Management's AVEO Pharmaceuticals, Inc. position peaked at $21.6M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Balyasny Asset Management's 13F filing for Q1 2023, filed 15 May 2023.